Pilot Study of Concurrent 5-Fluorouracil/Paclitaxel Plus Radiotherapy in Patients With Carcinoma of the Esophagus and Gastroesophageal Junction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pilot Study of Concurrent 5-Fluorouracil/Paclitaxel Plus Radiotherapy in Patients With Carcinoma of the Esophagus and Gastroesophageal Junction

Published:2001-02 Issue:1 Volume:24 Page:91-95
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology: Cancer Clinical Trials
language:en
Short-container-title:American Journal of Clinical Oncology: Cancer Clinical Trials

Author:

Schnirer Isac I.,Komaki Ritsuko,Yao James C.,Swisher Stephen,Putnam Joe,Pisters Peter W. T.,Roth Jack A.,Ajani Jaffer A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cancer statistics, 1999

2. Current Status of New Drugs and Multidisciplinary Approaches in Patients With Carcinoma of the Esophagus

3. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.

4. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.

5. A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Taxane- Versus Cisplatin-Based Chemotherapy With Radiation Therapy Is a Better Platform to Refine Esophageal Cancer Therapy;Journal of Clinical Oncology;2019-10-20

2. Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial;Journal of Clinical Oncology;2019-07-10

3. Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2);BMJ Open;2018-10

4. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma;Cellular Oncology;2018-08-16

5. Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype;Oncology Letters;2018-06-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3